VeriMom¿Es polyvinylacetamide seguro durante el embarazo?
No harmonised CLP classification, no SCCS or CIR reproductive safety opinion located, and no peer‑reviewed evidence of reproductive or teratogenic effects of poly(N‑vinylacetamide) or its use in cosmetics was found. Regulatory/INCI sources treat this as a polymer (polymer concerns typically focus on residual monomer). Sources searched showed INCI entries and substance pages but no harmonised flags or safety assessments for reproductive endpoints. ([cosmileeurope.eu](https://cosmileeurope.eu/inci/detail/12550/polyvinylacetamide/?utm_source=openai))
Related ingredients
Frequently asked questions
- ¿Es polyvinylacetamide seguro durante el embarazo?
- No harmonised CLP classification, no SCCS or CIR reproductive safety opinion located, and no peer‑reviewed evidence of reproductive or teratogenic effects of poly(N‑vinylacetamide) or its use in cosmetics was found. Regulatory/INCI sources treat this as a polymer (polymer concerns typically focus on residual monomer). Sources searched showed INCI entries and substance pages but no harmonised flags or safety assessments for reproductive endpoints. ([cosmileeurope.eu](https://cosmileeurope.eu/inci/detail/12550/polyvinylacetamide/?utm_source=openai))
- ¿Es polyvinylacetamide seguro durante la lactancia?
- No data found showing transfer to breast milk or adverse effects during lactation for polyvinylacetamide. No authoritative safety assessment (CIR/SCCS/harmonised CLP) raising reproductive/lactation concerns was identified; therefore default scoring is 0. Potential concern would relate to residual monomer (N‑vinylacetamide) if present, but no data on levels or breast‑milk transfer were located. ([cosmileeurope.eu](https://cosmileeurope.eu/inci/detail/12550/polyvinylacetamide/?utm_source=openai))
- ¿Es polyvinylacetamide seguro para la piel del bebé?
- No evidence of developmental or infant‑specific hazard was found. For exposure (e) infants have a less mature skin barrier and higher surface‑area‑to‑weight ratio; polymers like poly(N‑vinylacetamide) are generally of low dermal absorption, so adult exposure is negligible (e=0) but infant exposure is increased to e=1 to reflect higher potential per‑weight exposure and possibility of measurable absorption if small amounts of low‑molecular‑weight species (residual monomer) are present. There is no infant‑specific toxicology showing increased hazard. ([en.wikipedia.org](https://en.wikipedia.org/wiki/Poly%28N-vinylacetamide%29?utm_source=openai))
- ¿Cómo puntúa VeriMom a polyvinylacetamide?
- VeriMom puntúa polyvinylacetamide en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a polyvinylacetamide en el embarazo?
- Consulta nuestra lista de alternativas seguras a polyvinylacetamide según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.